Skip to main content
Top
Published in: Emerging Themes in Epidemiology 1/2017

Open Access 01-12-2017 | Commentary

Causality in cancer research: a journey through models in molecular epidemiology and their philosophical interpretation

Authors: Paolo Vineis, Phyllis Illari, Federica Russo

Published in: Emerging Themes in Epidemiology | Issue 1/2017

Login to get access

Abstract

In the last decades, Systems Biology (including cancer research) has been driven by technology, statistical modelling and bioinformatics. In this paper we try to bring biological and philosophical thinking back. We thus aim at making different traditions of thought compatible: (a) causality in epidemiology and in philosophical theorizing—notably, the “sufficient-component-cause framework” and the “mark transmission” approach; (b) new acquisitions about disease pathogenesis, e.g. the “branched model” in cancer, and the role of biomarkers in this process; (c) the burgeoning of omics research, with a large number of “signals” and of associations that need to be interpreted. In the paper we summarize first the current views on carcinogenesis, and then explore the relevance of current philosophical interpretations of “cancer causes”. We try to offer a unifying framework to incorporate biomarkers and omic data into causal models, referring to a position called “evidential pluralism”. According to this view, causal reasoning is based on both “evidence of difference-making” (e.g. associations) and on “evidence of underlying biological mechanisms”. We conceptualize the way scientists detect and trace signals in terms of information transmission, which is a generalization of the mark transmission theory developed by philosopher Wesley Salmon. Our approach is capable of helping us conceptualize how heterogeneous factors such as micro and macro-biological and psycho-social—are causally linked. This is important not only to understand cancer etiology, but also to design public health policies that target the right causal factors at the macro-level.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schulte PA, Perera FP. Molecular epidemiology: principles and practice. Cambridge: Academic Press; 1993. p. 588. ISBN 0-12-632346-1. Schulte PA, Perera FP. Molecular epidemiology: principles and practice. Cambridge: Academic Press; 1993. p. 588. ISBN 0-12-632346-1.
2.
go back to reference Vineis P, Stewart BW. How do we judge what causes cancer? The meat controversy. Int J Cancer. 2016;138(10):2309–11.CrossRefPubMed Vineis P, Stewart BW. How do we judge what causes cancer? The meat controversy. Int J Cancer. 2016;138(10):2309–11.CrossRefPubMed
3.
go back to reference Clarke B, Gillies D, Illari P. Mechanisms and the evidence hierarchy. Topoi. 2014;33:339–60.CrossRef Clarke B, Gillies D, Illari P. Mechanisms and the evidence hierarchy. Topoi. 2014;33:339–60.CrossRef
4.
go back to reference Gerlinger M, McGranahan N, Dewhurst SM, et al. Cancer: evolution within a lifetime. Annu Rev Genet. 2014;48:215–36.CrossRefPubMed Gerlinger M, McGranahan N, Dewhurst SM, et al. Cancer: evolution within a lifetime. Annu Rev Genet. 2014;48:215–36.CrossRefPubMed
5.
go back to reference New AM, Lehner B. Systems biology: network evolution hinges on history. Nature. 2015;523(7560):297–8.CrossRefPubMed New AM, Lehner B. Systems biology: network evolution hinges on history. Nature. 2015;523(7560):297–8.CrossRefPubMed
6.
go back to reference Smith MT, Guyton KZ, Gibbons CF, et al. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect. 2015;124(6):713.CrossRefPubMedPubMedCentral Smith MT, Guyton KZ, Gibbons CF, et al. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect. 2015;124(6):713.CrossRefPubMedPubMedCentral
7.
8.
go back to reference Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):S77–81.CrossRefPubMedPubMedCentral Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):S77–81.CrossRefPubMedPubMedCentral
9.
go back to reference Whiteman DC, Webb PM, Green AC, Neale RE, Fritschi L, Bain CJ, Parkin DM, Wilson LF, Olsen CM, Nagle CM, Pandeya N, Jordan SJ, Antonsson A, Kendall BJ, Hughes MC, Ibiebele TI, Miura K, Peters S, Carey RN. Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions. Aust N Z J Public Health. 2015;39(5):477–84.CrossRefPubMedPubMedCentral Whiteman DC, Webb PM, Green AC, Neale RE, Fritschi L, Bain CJ, Parkin DM, Wilson LF, Olsen CM, Nagle CM, Pandeya N, Jordan SJ, Antonsson A, Kendall BJ, Hughes MC, Ibiebele TI, Miura K, Peters S, Carey RN. Cancers in Australia in 2010 attributable to modifiable factors: summary and conclusions. Aust N Z J Public Health. 2015;39(5):477–84.CrossRefPubMedPubMedCentral
10.
go back to reference Shield KD, Parkin DM, Whiteman DC, Rehm J, Viallon V, Micallef CM, Vineis P, Rushton L, Bray F, Soerjomataram I. Population attributable and preventable fractions: cancer risk factor surveillance, and cancer policy projection. Curr Epidemiol Rep. 2016;3(2):201–11.CrossRefPubMed Shield KD, Parkin DM, Whiteman DC, Rehm J, Viallon V, Micallef CM, Vineis P, Rushton L, Bray F, Soerjomataram I. Population attributable and preventable fractions: cancer risk factor surveillance, and cancer policy projection. Curr Epidemiol Rep. 2016;3(2):201–11.CrossRefPubMed
11.
go back to reference Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2008. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2008.
12.
go back to reference Vineis P, Stringhini S, Porta M. The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization. Environ Res. 2014;133:424–30.CrossRefPubMed Vineis P, Stringhini S, Porta M. The environmental roots of non-communicable diseases (NCDs) and the epigenetic impacts of globalization. Environ Res. 2014;133:424–30.CrossRefPubMed
13.
go back to reference Scelo G, Riazalhosseini Y, Greger L, et al. Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat Commun. 2014;5:5135.CrossRefPubMed Scelo G, Riazalhosseini Y, Greger L, et al. Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat Commun. 2014;5:5135.CrossRefPubMed
14.
go back to reference Wild CP, Scalbert A, Herceg Z. Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk. Environ Mol Mutagen. 2013;54(7):480–99.CrossRefPubMed Wild CP, Scalbert A, Herceg Z. Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk. Environ Mol Mutagen. 2013;54(7):480–99.CrossRefPubMed
15.
go back to reference Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008;105(44):17046–9.CrossRefPubMedPubMedCentral Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008;105(44):17046–9.CrossRefPubMedPubMedCentral
16.
go back to reference Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P, STROBE Statement. STrengthening the reporting of observational studies in epidemiology-molecular epidemiology (STROBE-ME): an extension of the STROBE statement. PLoS Med. 2011;8(10):e1001117.CrossRefPubMedPubMedCentral Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P, STROBE Statement. STrengthening the reporting of observational studies in epidemiology-molecular epidemiology (STROBE-ME): an extension of the STROBE statement. PLoS Med. 2011;8(10):e1001117.CrossRefPubMedPubMedCentral
17.
go back to reference Vineis P, Chadeau-Hyam M. Integrating biomarkers into molecular epidemiological studies. Curr Opin Oncol. 2011;23(1):100–5.CrossRefPubMed Vineis P, Chadeau-Hyam M. Integrating biomarkers into molecular epidemiological studies. Curr Opin Oncol. 2011;23(1):100–5.CrossRefPubMed
18.
go back to reference Vineis P, Khan AE, Vlaanderen J, et al. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health. 2009;8:54.CrossRefPubMedPubMedCentral Vineis P, Khan AE, Vlaanderen J, et al. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health. 2009;8:54.CrossRefPubMedPubMedCentral
19.
go back to reference Thomas DC. High-volume “-omics” technologies and the future of molecular epidemiology. Epidemiology. 2006;17(5):490–1.CrossRefPubMed Thomas DC. High-volume “-omics” technologies and the future of molecular epidemiology. Epidemiology. 2006;17(5):490–1.CrossRefPubMed
20.
go back to reference Haack S. Defending science—within reason: between scientism and cynicism. New York: Prometheus Books; 2007. Haack S. Defending science—within reason: between scientism and cynicism. New York: Prometheus Books; 2007.
21.
go back to reference Pearce N, Blair A, Vineis P, et al. IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect. 2015;123(6):507–14.PubMedPubMedCentral Pearce N, Blair A, Vineis P, et al. IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect. 2015;123(6):507–14.PubMedPubMedCentral
22.
go back to reference Salmon WC. Scientific explanation and the causal structure of the world. Princeton: Princeton University Press; 1984. Salmon WC. Scientific explanation and the causal structure of the world. Princeton: Princeton University Press; 1984.
23.
go back to reference Salmon WC. Causality and explanation: a reply to two critiques. Philos Sci. 1997;64(3):461–77.CrossRef Salmon WC. Causality and explanation: a reply to two critiques. Philos Sci. 1997;64(3):461–77.CrossRef
24.
go back to reference Dowe P. Wesley Salmon’s process theory of causality and the conserved quantity theory. Br J Philos Sci. 1992;59(2):195–216.CrossRef Dowe P. Wesley Salmon’s process theory of causality and the conserved quantity theory. Br J Philos Sci. 1992;59(2):195–216.CrossRef
25.
go back to reference Dowe P. Causality and explanation: review of Salmon. Br J Philos Sci. 2000;51:165–74.CrossRef Dowe P. Causality and explanation: review of Salmon. Br J Philos Sci. 2000;51:165–74.CrossRef
26.
go back to reference Illari P, Williamson J. What is a mechanism? Thinking about mechanisms across the sciences. Eur J Philos Sci. 2012;2(1):119–35.CrossRef Illari P, Williamson J. What is a mechanism? Thinking about mechanisms across the sciences. Eur J Philos Sci. 2012;2(1):119–35.CrossRef
27.
go back to reference Illari P, Russo F. Information channels and biomarkers of disease. Topoi. 2016;35(1):175–90.CrossRef Illari P, Russo F. Information channels and biomarkers of disease. Topoi. 2016;35(1):175–90.CrossRef
28.
go back to reference Chadeau-Hyam M, Athersuch TJ, Keun HC, et al. Meeting-in-the-middle using metabolic profiling: a strategy for the identification of intermediate biomarkers in cohort studies. Biomarkers. 2011;16(1):83–8.CrossRefPubMed Chadeau-Hyam M, Athersuch TJ, Keun HC, et al. Meeting-in-the-middle using metabolic profiling: a strategy for the identification of intermediate biomarkers in cohort studies. Biomarkers. 2011;16(1):83–8.CrossRefPubMed
Metadata
Title
Causality in cancer research: a journey through models in molecular epidemiology and their philosophical interpretation
Authors
Paolo Vineis
Phyllis Illari
Federica Russo
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Emerging Themes in Epidemiology / Issue 1/2017
Electronic ISSN: 1742-7622
DOI
https://doi.org/10.1186/s12982-017-0061-7

Other articles of this Issue 1/2017

Emerging Themes in Epidemiology 1/2017 Go to the issue